Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2.
Pandey M, Ozberk V, Eskandari S, Shalash AO, Joyce MA, Saffran HA, Day CJ, Lepletier A, Spillings BL, Mills JL, Calcutt A, Fan F, Williams JT, Stanisic DI, Hattingh L, Gerrard J, Skwarczynski M, Mak J, Jennings MP, Toth I, Tyrrell DL, Good MF.
Pandey M, et al.
Clin Transl Immunology. 2021 Mar 7;10(3):e1260. doi: 10.1002/cti2.1260. eCollection 2021.
Clin Transl Immunology. 2021.
PMID: 33732459
Free PMC article.